1,285
Views
3
CrossRef citations to date
0
Altmetric
EDITORIAL

Forty-five years in oncology, 25 years with Acta Oncologica

Pages 1593-1598 | Received 09 Nov 2018, Accepted 09 Nov 2018, Published online: 29 Nov 2018

References

  • Larsson LG. 50 years with oncology. Acta Oncol. 1994;33:847.
  • Påhlman L, Glimelius B. Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand. 1984;150:331–335.
  • Glimelius B, Myklebust TÅ, Lundqvist K, et al. Two countries – two treatment strategies for rectal cancer. Radiother Oncol. 2016;121:357–363.
  • Sjovall A, Jarv V, Blomqvist L, et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol. 2004;30:834–841.
  • Noren A, Eriksson HG, Olsson LI. Selection for surgery and survival of synchronous colorectal liver metastases; a nationwide study. Eur J Cancer. 2016;53:105–114.
  • Brahme A. Design principles and clinical possibilities with a new generation of radiation therapy equipment. A review. Acta Oncol. 1987;26:403–412.
  • Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131–146.
  • Brahme A. Biologically based treatment planning. Acta Oncol. 1999;38 Suppl.13:61–68.
  • Lax I, Blomgren H, Naslund I, et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 1994;33:677–683.
  • Denekamp J, Fowler JF. ARCON-current status: summary of a workshop on preclinical and clinical studies. Acta Oncol. 1997;36:517–525.
  • Tubiana M, Eschwege F. Conformal radiotherapy and intensity-modulated radiotherapy–clinical data. Acta Oncol. 2000;39:555–567.
  • Thornqvist S, Hysing LB, Tuomikoski L, et al. Adaptive radiotherapy strategies for pelvic tumors – a systematic review of clinical implementations. Acta Oncol. 2016;55:943–958.
  • Glimelius B, Bergh J, Brandt L, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types – summary and conclusions. Acta Oncol. 2001;40:135–154.
  • Ishida Y, Agata Y, Shibahara K, et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11:3887–3895.
  • Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995;182:459–465.
  • Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976;34:585–612.
  • Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1–39.
  • Grau C, Hoyer M, Poulsen PR, et al. Rethink radiotherapy – BIGART 2017. Acta Oncol. 2017;56:1341–1352.
  • Johansen C, Dalton SO. Survivorship in new harbors. Acta Oncol. 2017;56:119–122.
  • Muren LP, Glimelius B. And they lived happily ever after… The marriage of Nordic Association for Clinical Physics and Acta Oncologica. Acta Oncol. 2011;50:835–837.
  • Glimelius B. Tell all the good news as soon as possible. Acta Oncol. 2016;55:1067–1068.
  • Glimelius B. More than 1000 new manuscripts in 2017. Acta Oncol. 2018;57:174–175.
  • Glimelius B. The 50-year anniversary of Acta Oncologica. Acta Oncol. 2014;53:1–2.
  • Glimelius B. 50 years with Acta Oncologica. Acta Oncol. 2013;52:1–2.
  • Glimelius B, Johansen C, Muren LP, et al. Acta Oncologica and a new generation of scientists in oncology. Acta Oncol. 2014;53:849–851.
  • Bockelman C, Engelmann BE, Kaprio T, et al. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2015;54:5–16.
  • Poulsen LO, Qvortrup C, Pfeiffer P, et al. Review on adjuvant chemotherapy for rectal cancer – why do treatment guidelines differ so much? Acta Oncol. 2015;54:437–446.
  • Therkildsen C, Bergmann TK, Henrichsen-Schnack T, et al. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: a systematic review and meta-analysis. Acta Oncol. 2014;53:852–864.
  • Glimelius B. Any progress in pancreatic cancer? Acta Oncol. 2016;55:255–258.
  • Glimelius B. What is most relevant in preoperative rectal cancer chemoradiotherapy – the chemotherapy, the radiation dose or the timing to surgery? Acta Oncol. 2016;55:1381–1385.
  • Glimelius B, Martling A. What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait? Acta Oncol. 2017;56:1139–1142.
  • Bockelman C, Glimelius B. Need for adjuvant chemotherapy after colon cancer surgery – has it decreased? Acta Oncol. 2017;56:629–633.
  • Glimelius B. Oncology in the Nordic countries—the role of Acta Oncologica? Acta Oncol. 2002;41:3–5.
  • Shen C, Bjork BC. ‘Predatory’ open access: a longitudinal study of article volumes and market characteristics. BMC Med. 2015;13:230

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.